Planet 13 Holdings (PLNH) Gains from Investment Securities (2020 - 2026)
Planet 13 Holdings (PLNH) reported Gains from Investment Securities of $97322.0 for Q1 2026, little changed year-over-year from $97322.0 in Q1 2025, and down 94.19% quarter-over-quarter from $1.7 million in Q4 2025.
Planet 13 Holdings (PLNH) Gains from Investment Securities (2020 - 2026) Analysis & Trends
Planet 13 Holdings (PLNH) has 7 years of Gains from Investment Securities data on file, last reported at $97322.0 in Q1 2026.
- Gains from Investment Securities for Q1 2026 came in at $97322.0, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $97322.0 (changed 0.0% YoY), and the FY2025 annual result was $97322.0, down 76.71% from the prior year.
- Gains from Investment Securities declined to $97322.0 in Q1 2026 per PLNH's latest filing, from $1.7 million in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $4.3 million in Q2 2022 and troughed at -$7.0 million in Q3 2022.
- A 5-year average of -$227508.6 and a median of $97322.0 in 2025 frame the typical range for Gains from Investment Securities.
- The sharpest annual moves came in 2022 and 2025: Gains from Investment Securities sank 341.32% in 2022, then soared 16179.57% in 2025.
- A 5-year view of Gains from Investment Securities shows it stood at -$184850.0 in 2022, then surged by 254.53% to $285656.0 in 2023, then sank by 96.4% to $10286.0 in 2024, then soared by 16179.57% to $1.7 million in 2025, then sank by 94.19% to $97322.0 in 2026.
- Business Quant data shows PLNH's Gains from Investment Securities at $97322.0 in Q1 2026, $1.7 million in Q4 2025, and $502000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn |
| 10 | Planet 13 Holdings | - | - | 9.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 97,322.00 |
| Mar 31, 2026 | 97,322.00 |
| Dec 31, 2025 | 1.67 Mn |
| Dec 31, 2025 | 1.67 Mn |
| Sep 30, 2025 | 502,000.00 |
| Sep 30, 2025 | 502,000.00 |
| Jun 30, 2025 | 366,397.00 |
| Jun 30, 2025 | 366,397.00 |
| Mar 31, 2025 | 97,322.00 |
| Mar 31, 2025 | 97,322.00 |
| Dec 31, 2024 | 10,286.00 |
| Dec 31, 2024 | 10,286.00 |
| Sep 30, 2024 | 83,333.00 |
| Sep 30, 2024 | 83,333.00 |
| Mar 31, 2024 | 83,333.00 |
| Mar 31, 2024 | 83,333.00 |
| Dec 31, 2023 | 285,656.00 |
| Dec 31, 2023 | 285,656.00 |
| Mar 31, 2023 | 792,518.00 |
| Mar 31, 2023 | 792,518.00 |